Synthesis of lambda light chain subtypes by stimulated and unstimulated mouse B cells

European Journal of Immunology
Y OnoderaH Eisen

Abstract

Inbred mouse make 3 lambda chain subtypes. The lambda 1 and lambda 3 chains have similar variable (V) regions (in both the same V gene segment [V lambda 1] is used), whereas lambda 2 and lambda 3 have similar constant (C) regions. Despite the lambda 1 and lambda 3 V region similarity, lambda 1 occurs much more frequently than lambda 3 (and lambda 2) in the serum immunoglobulins and antibody responses of most inbred strains of mice. To explore the basis for the lambda 1 predominance, we compared the rates of synthesis of the 3 subtypes and the frequencies of the B cells that synthesize them, focussing on "resting" (i.e., unstimulated) and on polyclonally stimulated B cells from spleens of unimmunized BALB/c mice. In resting cells the relative rates of synthesis and the relative frequencies of the respective B cells were in accord, indicating that the rate of lambda chain synthesis is approximately the same per resting B cell, regardless of the lambda subtype it produces. However, in the polyclonally stimulated cells, lambda 1 was made 7 times faster than lambda 2 and 10 times faster than lambda 3; normalizing these rates by the frequencies of the respective stimulated cells suggests that in stimulated B cells lambda 1 chains are...Continue Reading

References

Nov 1, 1978·The Journal of Experimental Medicine·W GeckelerM Cohn
Nov 1, 1978·The Journal of Experimental Medicine·T Cotner, H N Eisen
Jul 8, 1975·Biochemical and Biophysical Research Communications·J S Tkacz, O Lampen
Jan 1, 1978·Journal of Immunological Methods·J W Goding
Jun 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·L J Wysocki, V L Sato
Mar 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·K Blaser, H N Eisen
Jan 1, 1976·Journal of Immunological Methods·J W Goding
Oct 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·N Hozumi, S Tonegawa
Aug 15, 1975·European Journal of Biochemistry·R A Laskey, A D Mills
Mar 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·E Appella
Jan 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·T AzumaH N Eisen
Aug 1, 1981·European Journal of Immunology·T Takemori, K Rajewsky
Jan 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·B Blomberg, S Tonegawa
Jul 1, 1982·European Journal of Immunology·E B ReillyH N Eisen

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.